Gemcovac-19: India's first mRNA jab may soon join vaccine drive
Gennova Biopharmaceuticals submitted the data in the month of April followed by additional data in the month of May. Earlier last month, in an exclusive interview with ANI, Dr Sanjay Singh, Chief Executive Officer and Whole-time Director, Gennova Biopharmaceuticals Ltd, said that the company is ready to roll out India's first mRNA vaccine in 72 hours after the government's permission. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 11, 2022 Category: Pharmaceuticals Source Type: news

NTAGI likely to discuss soon data of India's first mRNA vaccine against Covid
Gennova Biopharmaceuticals submitted the data in the month of April followed by additional data in the month of May. Earlier last month, in an exclusive interview with ANI, Dr Sanjay Singh, Chief Executive Officer and Whole-time Director, Gennova Biopharmaceuticals Ltd, said that the company is ready to roll out India's first mRNA vaccine in 72 hours after the government's permission. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 11, 2022 Category: Pharmaceuticals Source Type: news

Indian pharma industry may rebound to 8-11 pc growth rate; inflationary pressures, regulatory norms key risks: Alkem
On the outlook for the domestic business, Alkem Laboratories said, "With easing out of COVID-19 restrictions, resumption of travel, normalisation of supply chain and manufacturing activities, reopening of schools and offices, and a resumption of deferred elective medical treatments, the Indian pharmaceutical industry is expected to rebound to a normalised growth rate of 8-11 per cent." (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 11, 2022 Category: Pharmaceuticals Source Type: news

Government proposes compensation for trial injuries
The draft bill proposes that any person (sponsor, clinical research organisation or any other organisation or investigator) who fails to provide required medical management or compensation shall be punishable with imprisonment, which may extend to one year, or with a fine which shall not be less than twice the amount of compensation. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 11, 2022 Category: Pharmaceuticals Source Type: news

Aurobindo Pharma on track to develop complex products, expand global footprint
"In the US, around 220 abbreviated new drug applications (ANDAs) are awaiting final approval..With the pandemic situation easing, your company will resume its development trajectory, with a focus on developing a product range of complicated injectables," it informed shareholders. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 10, 2022 Category: Pharmaceuticals Source Type: news

Aurobindo calls off Eugia Pharma Specialities sale on valuation mismatch
Mails to Aurobindo, Blackstone and Baring PE Asia did not generate a response as of press time Friday. Eugia consists of general injectable, oncology injectable, oncology oral solids, and hormonals. In the last three months, Aurobindo's stock has fallen 22%, underperforming the Nifty Pharma Index which is down 10.46% and the benchmark Nifty 50 which slipped 8.7%. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 9, 2022 Category: Pharmaceuticals Source Type: news

Dr Reddy's Laboratories launches generic version of fesoterodine fumarate tablets in US
The company's fesoterodine fumarate extended-release tablets are available in 4 mg and 8 mg tablets, each in bottle count sizes of 30. These are the therapeutic generic equivalent of Toviaz, it added. Citing IQVIA data, Dr Reddy's said the Toviaz brand had US sales of approximately USD 211 million for the most recent 12 months ended May 2022. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 8, 2022 Category: Pharmaceuticals Source Type: news

Pharma businesses with strong quality compliance to emerge stronger as pandemic impact decreases: Ajay Piramal
Stressing that maintaining a strong focus on quality and compliance is another important area of growing significance in the pharma sector, Piramal Enterprises Ltd Chairman Ajay G Piramal said, "As the impact of the pandemic decreases, pharma businesses that have a strong track record of quality compliance and can remain agile towards new regulatory requirements, will emerge stronger." (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 8, 2022 Category: Pharmaceuticals Source Type: news

Dr Reddy's Laboratories says its Andhra plant gets two observations from USFDA
The US Food and Drug Administration (USFDA) completed a pre-approval inspection at the company's formulations manufacturing facility FTO 11 in Srikakulam, Andhra Pradesh on Thursday, Dr Reddy's said in a regulatory filing. The inspection was conducted from June 30, 2022 to July 7, 2022. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 7, 2022 Category: Pharmaceuticals Source Type: news

Generics of MSD diabetes pill set to flood market as patent expires
According to market research firm AIOCD, at least 50 Indian drug makers are jumping into the fray with around 100 generic versions of the popular anti-diabetes medication, leading to a likely price war. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 6, 2022 Category: Pharmaceuticals Source Type: news

DCGI recommends allowing SII to manufacture, stockpile qHPV vaccine against cervical cancer: Source
Prakash Kumar Singh, Director, Government and Regulatory Affairs at SII, had written to the Health Ministry on February 4 seeking approval to manufacture and stockpile the qHPV vaccine as a priority for public health, to save time in making it and to ensure its early availability, an official source said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 6, 2022 Category: Pharmaceuticals Source Type: news

Zydus Wellness proactively looking for acquisitions; to enter new overseas markets
"The company is confident to drive growth and increase the market share of its brands through innovation, leveraging distribution channels and expanding the brand portfolio," said Zydus Wellness. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 6, 2022 Category: Pharmaceuticals Source Type: news

Income Tax Department raids Dolo-650 manufacturer Micro Lab office in Bengaluru
Sources in the I-T department said that the simultaneous raids were conducted in 40 locations by 200 officers across the country, including New Delhi, Sikkim, Punjab, Tamil Nadu and Goa. The residences of Micro Labs CMD Dileep Surana, Director Anand Surana were also being raided, sources said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 6, 2022 Category: Pharmaceuticals Source Type: news

Diagnostic chain Redcliffe Labs to raise $200 million
"We are very keen to acquire regional (radiology testing) chains who already have a footprint, so that we can bring our quality, aggression and latest technology, to scale up the business," Dheeraj Jain, founder of Redcliffe Labs, said, adding he had begun scouting for potential targets of acquisitions. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 6, 2022 Category: Pharmaceuticals Source Type: news

Sanofi launches global health brand, to offer 30 meds on non-profit basis
The treatments will be provided under the new Impact brand, part of Sanofi's global health unit launched last year, which sits outside the commercial business. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 5, 2022 Category: Pharmaceuticals Source Type: news